Patents by Inventor Jun Okumura

Jun Okumura has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4231928
    Abstract: The penicillins of the formulae ##STR1## in which R.sup.1 is phenyl, 2-thienyl, 3-thienyl, cyclohexyl, cyclohexen-1-yl, cyclohexa-1,4-dienyl, cyclohexa-1,4-dienylmethyl, 4-methoxycyclohexa-1,4-dienylmethyl or one of certain 4-substituted or 3,4-disubstituted phenyl moieties, and their pharmaceutically acceptable salts and physiologically hydrolyzed esters possess antibacterial activity and are particularly valuable in treating Pseudomonas infections.
    Type: Grant
    Filed: April 24, 1979
    Date of Patent: November 4, 1980
    Assignee: Bristol-Myers Company
    Inventors: Takayuki Naito, Jun Okumura, Hajime Kamachi
  • Patent number: 4206116
    Abstract: The penicillin of the formula ##STR1## and its pharmaceutically acceptable salts and physiologically hydrolyzed esters possess antibacterial activity and are particularly valuable in treating Pseudomonas infections.
    Type: Grant
    Filed: December 7, 1978
    Date of Patent: June 3, 1980
    Assignee: Bristol-Myers Company
    Inventors: Takayuki Naito, Jun Okumura, Hideaki Hoshi
  • Patent number: 4198504
    Abstract: 7-[.alpha.-(4-hydroxy-1,5-naphthyridine-3-carboxamido)-.alpha.-phenyl or thienyl (and substituted phenyl) acetamido]-3-(pyridiniummethyl)-3-cephem-4-carboxylates having on the pyridine ring an acidic group which is preferably --COOH or --SO.sub.3 H and also, if desired, having one or two methylene groups together with or without a hetero atom between the pyridine ring and the acidic group were synthesized and found to have potent antibacterial activity in vitro especially against many strains of Pseudomonas aeruginosa and also high solubility in water.
    Type: Grant
    Filed: November 2, 1978
    Date of Patent: April 15, 1980
    Assignee: Bristol-Myers Company
    Inventors: Takayuki Naito, Jun Okumura, Masahisa Oka
  • Patent number: 4198506
    Abstract: Certain 7-acylamido-3-(2-carboxyalkyl-2,3-dihydro-s-triazolo[4,3-b]pyridazin-3-on- 6-ylthiomethyl)-3-cephem-4-carboxylic acids and their salts and easily hydrolyzed esters of the 4-carboxyl group were synthesized and found to be potent antibacterial agents which exhibited good aqueous solubility. A preferred embodiment was 7-[o-(methylaminomethyl)phenylacetamido]-3-(2-carboxyalkyl-2,3-dihydro-s-t riazolo[4,3-b]pyridazin-3-on-6-ylthiomethyl)-3-cephem-4-carboxylic acid.
    Type: Grant
    Filed: March 21, 1979
    Date of Patent: April 15, 1980
    Assignee: Bristol-Myers Company
    Inventors: Takayuki Naito, Jun Okumura, Hajime Kamachi, Seiji Iimura, Hideaki Hoshi, Masahisa Oka
  • Patent number: 4151352
    Abstract: Certain 7-acylamido-3-(2-carboxyalkyl-2,3-dihydro-s-triazolo[4,3-b]pyridazin-3-on- 6-ylthiomethyl)-3-cephem-4-carboxylic acids and their salts and easily hydrolyzed esters of the 4-carboxyl group were synthesized and found to be potent antibacterial agents which exhibited good aqueous solubility. A preferred embodiment was 7-[o-(methylaminomethyl)phenylacetamido]-3-(2-carboxyalkyl-2,3-dihydro-s-t riazolo[4,3-b]pyridazin-3-on-6-ylthiomethyl)-3-cephem-4-carboxylic acid.
    Type: Grant
    Filed: February 13, 1978
    Date of Patent: April 24, 1979
    Assignee: Bristol-Myers Company
    Inventors: Takayuki Naito, Jun Okumura, Hajime Kamachi, Seiji Iimura, Hideaki Hoshi, Masahisa Oka
  • Patent number: 4138554
    Abstract: 7-[D-.alpha.-(4-hydroxy-1,5-naphthyridine-3-carboxyamido)-.alpha.-phenyl (and p-hydroxyphenyl) acetamido]-3-carbamoyloxymethyl-3-cephem-4-carboxylic acids were synthesized and found to have potent antibacterial activity in vitro especially against many strains of Pseudomonas aeruginosa.
    Type: Grant
    Filed: June 9, 1977
    Date of Patent: February 6, 1979
    Assignee: Bristol-Myers Company
    Inventors: Takayuki Naito, Jun Okumura, Masahisa Oka
  • Patent number: 4112228
    Abstract: 7-(D-.alpha.-Hydroxy-2-arylacetamido)-3-(2-carboxyalkyl-2,3-dihydro-s-triaz olo[4,3-b]pyridazin-3-on-6-ylthiomethyl)-3-cephem-4-carboxylic acids and derivatives containing blocking groups on the .alpha.-hydroxy group and their nontoxic, pharmaceutically acceptable salts are valuable as antibacterial agents and are particularly valuable as therapeutic agents in poultry and in animals, including man, in the treatment of infectious diseases caused by many Gram-positive and Gram-negative bacteria. A preferred compound is 7-(D-mandelamido)-3-(2-carboxyalkyl-2,3-dihydro-s-triazolo[4,3-b]pyridazin -3-on-6-ylthiomethyl)-3-cephem-4-carboxylic acid.
    Type: Grant
    Filed: March 16, 1977
    Date of Patent: September 5, 1978
    Assignee: Bristol-Myers Company
    Inventors: Takayuki Naito, Jun Okumura, Hajime Kamachi
  • Patent number: 4104469
    Abstract: Cephalosporins in a series having the formula ##STR1## wherein R.sup.1 is alkyl containing 1-4 carbon atoms or a nontoxic pharmaceutically acceptable salt thereof, were synthesized and found to be potent antibacterial agents especially when in the form of the syn isomers essentially free of the corresonding anti isomer.
    Type: Grant
    Filed: April 15, 1977
    Date of Patent: August 1, 1978
    Assignee: Bristol-Myers Company
    Inventors: Takayuki Naito, Jun Okumura, Seiji Iimura
  • Patent number: 4103085
    Abstract: Cephalosporins in a series having the formula ##STR1## wherein R.sup.1 is alkyl containing 1-4 carbon atoms and n is 1 or 2 or a nontoxic pharmaceutically acceptable salt thereof, were synthesized and found to be potent antibacterial agents especially when in the form of the syn isomers essentially free of the corresponding anti isomer.
    Type: Grant
    Filed: February 24, 1977
    Date of Patent: July 25, 1978
    Assignee: Bristol-Myers Company
    Inventors: Takayuki Naito, Jun Okumura, Seiji Iimura
  • Patent number: 4082912
    Abstract: Certain 7-acylamido-3-(2-carboxyalkyl-2,3-dihydro-s-triazolo[4,3-b]pyridazin-3-on- 6-ylthiomethyl)-3-cephem-4-carboxylic acids and their salts and easily hydrolyzed esters of the 4-carboxyl group were synthesized and found to be potent antibacterial agents which exhibited good aqueous solubility. A preferred embodiment was 7-[o-(methylaminomethyl)phenylacetamido]-3-(2-carboxyalkyl-2,3-dihydro-s-t riazolo[4,3-b]pyridazin-3-on-6-ylthiomethyl)-3-cephem-4-carboxylic acid.
    Type: Grant
    Filed: April 5, 1977
    Date of Patent: April 4, 1978
    Assignee: Bristol-Myers Company
    Inventors: Takayuki Naito, Jun Okumura, Hajime Kamachi, Seiji Iimura, Hideaki Hoshi, Masahisa Oka
  • Patent number: 3985738
    Abstract: 7-(D-.alpha.-Hydroxy-2-arylacetamido)-3-(tetrazolo-[4,5-b]pyridazin-6-ylthi omethyl)-3-cephem-4-carboxylic acids and their nontoxic, pharmaceutically acceptable salts are valuable as antibacterial agents and are particularly valuable as therapeutic agents in poultry and animals, including man, in the treatment of infectious diseases caused by many Gram-positive and Gram-negative bacteria.
    Type: Grant
    Filed: May 24, 1974
    Date of Patent: October 12, 1976
    Assignee: Bristol-Myers Company
    Inventors: Takayuki Naito, Jun Okumura, Hajime Kamachi
  • Patent number: 3946000
    Abstract: 7-[.alpha.-(2-Aminomethyl-1-cyclohexyl)-acetamido]-3-heterocyclic thiomethyl-3-cephem-4-carboxylic acids, and their nontoxic, pharmaceutically acceptable salts and their Schiff bases, as made by reaction of salicylaldehyde with the free amino group, are valuable as antibacterial agents and are particularly valuable as therapeutic agents in poultry and animals, including man, in the treatment of infectious diseases caused by many Gram-positive and Gram-negative bacteria.
    Type: Grant
    Filed: October 31, 1973
    Date of Patent: March 23, 1976
    Assignee: Bristol-Myers Company
    Inventors: Takayuki Naito, Jun Okumura, Hajime Kamachi